Rethinking the effectiveness of hypomethylating agents in myelodysplastic syndromes: the 50%-2-year wall

類似資料

• Lymphoid aggregates in the bone marrow biopsies of patients with myelodysplastic syndromes – A potential prognostic marker?
  著者:: Reut Book, 等
  出版事項: (2023-01-01)
• Fidelity of peripheral blood for monitoring genomics and tumor immune‐microenvironment in myelodysplastic syndromes
  著者:: Sung‐Eun Lee, 等
  出版事項: (2020-11-01)
• Myelodysplastic syndrome in a 30-year-old man with coronavirus disease 2019 (COVID-19): a diagnostic challenge
  著者:: Xin Qing, 等
  出版事項: (2021-04-01)
• THROMBOCYTOPENIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - STILL AN UNSOLVED PROBLEM
  著者:: May Basood, 等
  出版事項: (2018-07-01)
• Erythrophagocytosis by neutrophils and megakaryocytic emperipolesis are distinctive morphologic features in del(20q)-associated myelodysplastic syndrome
  著者:: Min Shi, MD, PhD, 等
  出版事項: (2017-06-01)